Published 16 February 2016 Recently, the Lund University alumni Bertil P. Lundqvist, made a donation to the MAD for Cancer program, his American employer Starr Companies matched the amount. This procedure is called "Employee Matching Gift" and is a common form of philanthropic giving in the United States. This is the first time, Starr Companies give a donation to cancer research outside the US. Be

https://www.madforcancer.lu.se/article/us-based-starr-companies-made-donation-mad-cancer - 2025-03-09

Published 23 March 2016 Forskare från fyra fakulteter vid Lunds universitet samlar sin expertkunskap för att studera cancer ur flera perspektiv. Målet är bättre och tidigare metoder för diagnos och behandling, och att patienter snabbt ska gynnas av resultaten. Det så kallade MAD for Cancer-programmet får 2 miljoner kronor från Mats Paulssons stiftelse för forskning, innovation och samhällsbyggande

https://www.madforcancer.lu.se/article/donation-ger-skjuts-forskning-som-tar-helhetsgrepp-pa-tumorer - 2025-03-09

Published 6 April 2016 The patent application covers IL1RAP as a target molecule for antibody therapy and leukemia diagnostics. The IL1RAP originates from the research of Prof Thoas Fioretos. For more information

https://www.madforcancer.lu.se/article/cantargia-receives-patent-approval-japan-and-mexico - 2025-03-09

Published 8 April 2016 Based on recent results from retrospective studies, that are now under publication, we can differentiate the early resectable stages of pancreatic cancer, stage I and II, from the healthy controls with 96% accuracy. Read the article hear

https://www.madforcancer.lu.se/article/pancreatic-cancer-nordic-newsletter-includes-research-create-health - 2025-03-09

Published 8 April 2016 Researchers from CREATE Health have been highlighted in an article in the yearly report of the Swedish Cancer Society. The report briefly describes highly interesting studies by Åke Borg, Lisa Rydén, Lao Saal and Carl Borrebaeck. Read the article here

https://www.madforcancer.lu.se/article/create-health-research-cancerfondsrapporten-2016 - 2025-03-09

Published 4 May 2016 Pietras and his colleagues recently discovered that high levels of the ALK1 protein is linked to the spread of breast cancer and that there is an opportunity to inhibit this by blocking ALK1. Read the article here

https://www.madforcancer.lu.se/article/breakthrough-professor-kristian-pietras-highlighted-cancerfonden - 2025-03-09

Published 13 June 2016 Prof Thoas Fioretos and his research team has performed a detailed study of leukemia cells from over 200 children and discovered two new subtypes of childhood leukemia. Read the article here

https://www.madforcancer.lu.se/article/new-variants-blood-cancer-children - 2025-03-09

Published 29 August 2017 Professor Håkan Axelsson and his team have identified a series of gene expression programs that are characteristic for specific cell types of the nephron. This can be used to define the histological origin of kidney cancer which is significant for diagnostics and, in the long term, also for the choice of treatment. To the full article

https://www.madforcancer.lu.se/article/improved-gene-analysis-kidney-cancer-defines-kidney-cancer-subtypes - 2025-03-09

Published 18 September 2017 Kristian Pietras, professor i molekylär medicin, har utsetts till Lunds universitets egen Fernströmpristagare. Han får priset för sin banbrytande forskning om samspelet mellan tumörceller och deras omgivning, vilket kan leda till nya behandlingar vid cancer.  En tumör består av cancerceller som förökar sig på ett okontrollerat sätt. Den här processen drivs av genetiska

https://www.madforcancer.lu.se/article/lunds-fernstrompris-till-forskning-om-cancercellers-samspel-med-omgivningen - 2025-03-09

Published 1 October 2020 New treatment for aggressive breast cancer The researcher team lead by Professor Kristian Pietras has developed a new drug that transforms aggressive breast cancer so that it becomes responsive to standard hormone therapy. Approximately 10–15 per cent of breast cancer cases do not respond to treatment with hormone therapy, which means that they are more aggressive and ofte

https://www.madforcancer.lu.se/article/professor-kristian-pietras-publish-new-study-nature-medicine - 2025-03-09

Published 2 October 2020 Professor Thoas Fioretos, one of CREATE healths principal investigators is one of 4 active chief physicians who was awarded this years Wallenbergs Clinical fellow grant. As a Wallenberg Clinical Scholar, he will develop new methods to improve diagnostics, treatment selection, and follow-up of patients diagnosed with leukemia. The project will also provide important insight

https://www.madforcancer.lu.se/article/professor-thoas-fioretos-wallenberg-clinical-fellow - 2025-03-09

Published 2 October 2020 Within Mad for Cancer we use a multidisciplinary approach to defeat cancer. We utilize knowledge from research areas such as cancer stem cells, immuno-oncology, tumor micro-environment, and the psychological effect on cancer. This approach has been very rewarding, and the outcome was presented in DN today. We know today that knowledge from several different therapy areas i

https://www.madforcancer.lu.se/article/multifocal-strategy-fight-cancer - 2025-03-09

Published 6 October 2020 Professor Carl Borrebaeck, held an inspiring talk at TEDxLund, www.tedxlund.se, hosted by Medicon Village and MAX IV. The theme of TEDxLund "Prima Materia." The event featured speakers, presenting in front of an audience, and was recorded in its entirety and then streamed to another 100 audience members at Medicon Village (Auditorium). In the spirit of ideas worth spreadin

https://www.madforcancer.lu.se/article/tedx-lund - 2025-03-09

Published 9 October 2020 In some cancers, connective tissue is formed around and within the tumor. A hypothesis, which has not been proven so far, is that there are several different types of connective tissue cells that have different functions and which can thus affect tumor development in different ways. But now a research group at Lund University has identified three different types of connect

https://www.madforcancer.lu.se/article/wrong-type-connective-tissue-cells-gives-worse-prognosis-breast-cancer - 2025-03-09

Published 9 October 2020 Kristian Pietras, Professor of Molecular Medicine at the Department of Laboratory Medicine, has been awarded the Göran Gustafsson Prize in Medicine for "his breakthrough analysis of the cancer-associated microenvironment and its role in tumour development". In his research he has systematically studied which cell types tumours are constructed of and how these communicate w

https://www.madforcancer.lu.se/article/kristian-pietras-awarded-goran-gustafsson-prize - 2025-03-09

Published 9 October 2020 Mårten Fernö and Åke Borg, both breast cancer researchers at Lund University, received the Breast Cancer Association Award 2019. In more than 40 years, the two scientists have developed methods to distinguish patients that need additional treatment after cancer surgery from those for whom an operation is sufficient and extra treatment would only cause unnecessary stress. N

https://www.madforcancer.lu.se/article/breast-cancer-association-award-2019 - 2025-03-09

Published 9 October 2020 This November, MAD for Cancer researchers participated in the popular science show ’Om X Antal År’ (in so many years) hosted by Cecilia Nebel and comedian Jesper Rönndal at Medicon Village, Lund. Combining research and humor, the show addressed some pressing questions regarding our future. How can we get really old? And how will we fight disease? Director Carl Borrebaeck a

https://www.madforcancer.lu.se/article/mad-cancer-stage - 2025-03-09

By asa [dot] hansdotter [at] med [dot] lu [dot] se (Åsa Hansdotter) - published 9 March 2022 Charlotta Böiers, head of StemTherapy FACS Core Facility research infrastructure, and Mikael Sommarin, research engineer, discuss the results of a 22-colour analysis made on the new FACS device Symphony S6. Photo: Åsa Hansdotter. Anna Fossum, Project Manager at the StemTherapy FACS Core Facility research i

https://www.medicine.lu.se/article/new-addition-lund-stem-cell-center-facs-facility - 2025-03-09

By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 14 March 2022 Magdalena Götz, a professor of physiology at Ludwig Maximilian University of Munich, held the prestigious Segerfalk lecture 2021. (Photo: private) Magdalena Götz, a professor of physiology at Ludwig Maximilian University of Munich, held the prestigious Segerfalk lecture last year. The discovery she made as a youn

https://www.medicine.lu.se/article/control-experiment-transformed-entire-research-field - 2025-03-09

Published 17 March 2022 To the left: Petri dishes for cell cultures in the lab. To the right: Cells from the cell line the researchers used in the study. (Photo: Massimo De Marinis and Yang de Marinis) A new study from Lund University in Sweden on how the Pfizer-BioNTech COVID-19 vaccine affects human liver cells under experimental conditions, has been viewed more than 800,000 times in just over a

https://www.medicine.lu.se/article/qa-covid-19-vaccine-study-gains-attention - 2025-03-09